BMD4722|CAS 496920-98-0|DC Chemicals

Cas No.:	496920-98-0
Chemical Name:	BMD4722
SMILES:	O=C(O)CN1C2=C(C(CCC2)=O)C(C3=CC(OCC)=C(OCC4=CC=C(C)C=C4)C(Br)=C3)C5=C1CCCC5=O
Formula:	C₃₁H₃₂BrNO₆
M.Wt:	594.5

MSDS

Cat. No.	Product name	Field of application
DC74451	NPL-4011	NPL-4011 is a specific small molecule inhibitor of PDZ domain of human Dvl1 (Dvl1-PDZ) with KD vaule of 34.5 uM in NMR titration experiments.
DC74450	BMD4722	BMD4722 is a highly potent, small-molecule inhibitor of Dvl-CXXC5 interaction with IC50 of 2.59 uM, directly binds to the Dvl PDZ domain (Kd=22.3 uM).
DC74449	BMD4702	BMD4702 is a small molecule Dishevelled (Dvl) PDZ domain with binding Kd of 186 nM.
DC70553	KY19334	KY19334 is a specific small molecule inhibitor of CXXC5-Dishevelled (Dvl) protein-protein interaction (PPI), restores the Wnt/β‐catenin signalling.KY19334 reverses obesity‐related metabolic diseases with adult tissue remodelling.Oral administration of KY19334 (25 mg/kg) suppressed fasting glucose levels improves obesity‐related insulin resistance with long‐lasting effect in HFD‐fed mice.KY19334 treatment improves hepatic glucose homeostasis. KY19334 enhances energy expenditure by increasing the thermogenic activity of beige‐fat tissues.KY19334 treatment restores β‐cell mass and functions in HFD‐fed and STZ‐induced diabetes mellitus (DM) mice.